A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis

NCT00568412 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild to Moderate Atopic Dermatitis

Interventions

DEVICE: Zarzenda
DRUG: Elidel

Sponsor

Bayer